Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash
Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash
Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash
Submitted by
admin
on October 13, 2015 - 12:16pm
Source:
Fierce Biotech
News Tags:
Protalix BioTherapeutics
Pfizer
R&D
Gaucher disease
Elelyso
Headline:
Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash
Do Not Allow Advertisers to Use My Personal information